medric medric
잠시만 기다려 주세요. 로딩중입니다.

갈망감의 신경생물학적 기전과 항갈망제의 임상적 사용

Neurobiological Basis of Craving and Anti-Craving Medications

신경정신의학 2019년 58권 3호 p.167 ~ 172
정영철 ( Jung Young-Chul ) - 연세대학교 의과대학 정신건강의학교실


Clinical studies published over the past two decades have consistently demonstrated the therapeutic efficacy and safety of anti-craving medications. To use anti-craving agents more effectively in clinical settings, it is important to set clear treatment goals. Because alcoholic patients have lost control of drinking alcohol, it is recommended to set ‘abstinence’ as a goal rather than ‘controlled drinking’. Indeed, the therapeutic effects of anti-craving medication are higher when abstinence is set as the target. On the other hand, if abstinence is the sole criterion, it is difficult to elicit the motivation of a patient who lacks motivation in clinical practice. In the case of patients who have not yet gained insight, the initial goal might be set to gradually reduce the amount of alcohol consumed and prevent at-risk heavy drinking. Even in this case, anti-craving can help clinically. To increase the effectiveness of anti-craving medications, it is best to start at least four to seven days after the patient has stopped drinking. If the patient has alcohol withdrawal symptoms, they should be treated first.


Alcohol use disorder; Craving; Naltrexone; Acamprosate
원문 및 링크아웃 정보
등재저널 정보